Literature DB >> 10411594

The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats.

S A Kushner1, S L Dewey, C Kornetsky.   

Abstract

gamma-Vinyl gamma-aminobutyric acid (GABA) (GVG) is an irreversible inhibitor of GABA transaminase, the primary enzyme involved in GABA metabolism. Acute administration of GVG increases brain GABA levels and blocks cocaine-induced locomotor activity, cocaine-induced lowering of brain stimulation reward thresholds, and cocaine-induced conditioned place preference. To further evaluate the effects of GVG on cocaine-induced reward, we examined its effects on cocaine self-administration in male Wistar rats on fixed ratio 5 and progressive ratio schedules of reinforcement. Additionally, the effects of GVG on operant responding for a food reward were examined on the same two schedules to determine whether the effects of GVG were specific to cocaine reward or generalized to other types of reward. GVG dose dependently decreased responding for cocaine on both schedules of reinforcement, suggesting that GVG attenuated the reward value of the cocaine. Responding for food was also decreased by GVG, suggesting that the effects of increased GABA levels induced by GVG may have a general effect on central reward systems. Data from this and other studies indicate that GVG does not induce motor impairment, decrease spontaneous locomotor activity, or induce catalepsy. Taken together, these data suggest that increases in GABAergic activity induced by GVG have an attenuating effect on centrally mediated reward systems and that the GABA system may be a useful target in the development of new therapeutic strategies for cocaine addiction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411594

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  33 in total

1.  GABA(C) receptors modulate the rod-driven ERG b-wave of the skate retina.

Authors:  Richard L Chappell; Etha Schuette; Robert Anton; Harris Ripps
Journal:  Doc Ophthalmol       Date:  2002-09       Impact factor: 2.379

2.  The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.

Authors:  Richard B Silverman
Journal:  J Med Chem       Date:  2012-01-10       Impact factor: 7.446

3.  Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats.

Authors:  Małgorzata Filip; Małgorzata Frankowska; Magdalena Zaniewska; Anna Gołda; Edmund Przegaliński; Jerzy Vetulani
Journal:  Psychopharmacology (Berl)       Date:  2007-01-26       Impact factor: 4.530

4.  Use of animal models to develop antiaddiction medications.

Authors:  Eliot L Gardner
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

Review 5.  Addiction and brain reward and antireward pathways.

Authors:  Eliot L Gardner
Journal:  Adv Psychosom Med       Date:  2011-04-19

Review 6.  Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Authors:  Stephanie C Licata; Perry F Renshaw
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

7.  Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.

Authors:  Chris C Streeter; John Hennen; Yong Ke; J Eric Jensen; Ofra Sarid-Segal; Leanne E Nassar; Clifford Knapp; Angela A Meyer; Tae Kwak; Perry F Renshaw; Domenic A Ciraulo
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

8.  Enantiomers of 4-amino-3-fluorobutanoic acid as substrates for gamma-aminobutyric acid aminotransferase. Conformational probes for GABA binding.

Authors:  Michael D Clift; Haitao Ji; Gildas P Deniau; David O'Hagan; Richard B Silverman
Journal:  Biochemistry       Date:  2007-11-08       Impact factor: 3.162

Review 9.  Plasticity of addiction: a mesolimbic dopamine short-circuit?

Authors:  Jason L Niehaus; Nelson D Cruz-Bermudez; Julie A Kauer
Journal:  Am J Addict       Date:  2009 Jul-Aug

10.  The search for medications to treat stimulant dependence.

Authors:  Kyle M Kampman
Journal:  Addict Sci Clin Pract       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.